Article Text

Download PDFPDF
Association of medication beliefs and self-efficacy with adherence in urban Hispanic and African–American rheumatoid arthritis patients
  1. Tanya M Spruill1,
  2. Gbenga Ogedegbe1,
  3. Leslie R Harrold2,
  4. Jeffrey Potter3,
  5. Jose U Scher3,
  6. Pamela B Rosenthal3,
  7. Jeffrey D Greenberg3
  1. 1 Department of Population Health, New York University School of Medicine, New York, New York, USA
  2. 2 Departments of Orthopedics and Physical Rehabilitation and Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  3. 3 Department of Medicine (Rheumatology), New York University School of Medicine, New York, New York, USA
  1. Correspondence to Dr Tanya M Spruill, Center for Healthful Behavior Change, Department of Population Health, New York University School of Medicine, 227 East 30th Street, 6th floor, Room 640, New York, NY 10016, USA; tanya.spruill{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Adherence to rheumatoid arthritis (RA) medications varies widely but is frequently suboptimal1 and is particularly poor among racial/ethnic minority patients,2 which may help to explain the growing evidence of disparities in RA clinical outcomes.2 Beliefs about medications and self-efficacy perceptions (ie, confidence) regarding medication-taking behaviour are two modifiable patient factors that have been associated with adherence to RA medications in largely Caucasian study samples.1 Minority RA patients report more negative medication beliefs and lower self-efficacy compared with Caucasians,35 but to our knowledge, the relationship between these psychological factors and medication adherence in these groups has not been reported.

We addressed this question in a cross-sectional study of 56 urban Hispanic and African–American RA patients recruited consecutively from the waiting rooms of two NYU-affiliated rheumatology clinics in New York City (Bellevue Hospital and Hospital for Joint Diseases) between November 2012 and January 2013. All …

View Full Text


  • Contributors TMS and JDG: study conception and design, data analysis and interpretation, drafting the article. GO, LRH and JP: data analysis and interpretation, critical revision of article. JS and PR: data acquisition and interpretation, critical revision of article. All authors gave final approval of the version to be published.

  • Funding This study was supported in part by grant UL1 TR000038 from the National Center for the Advancement of Translational Science (NCATS), National Institutes of Health.

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval NYU Institutional Review Board.

  • Provenance and peer review Not commissioned; internally peer reviewed.